CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT), 13294-13295 [2019-06607]

Download as PDF 13294 Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices Board of Governors of the Federal Reserve System, April 1, 2019. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2019–06586 Filed 4–3–19; 8:45 am] BILLING CODE P FEDERAL RESERVE SYSTEM Government in the Sunshine Meeting Notice; Agency Holding the Meeting: Board of Governors of the Federal Reserve System TIME AND DATE: 10:00 a.m. on Monday, April 8, 2019. Marriner S. Eccles Federal Reserve Board Building, 20th Street entrance between Constitution Avenue and C Streets NW, Washington, DC 20551. STATUS: Open. On the day of the meeting, you will be able to view the meeting via webcast from a link available on the Board’s public website. You do not need to register to view the webcast of the meeting. A link to the meeting documentation will also be available approximately 20 minutes before the start of the meeting. Both links may be accessed from the Board’s public website at www.federalreserve.gov. If you plan to attend the open meeting in person, we ask that you notify us in advance and provide your name, date of birth, and social security number (SSN) or passport number. You may provide this information by calling 202–452– 2474 or you may register online. You may pre-register until close of business on Friday, April 5, 2019. You also will be asked to provide identifying information, including a photo ID, before being admitted to the Board meeting. The Public Affairs Office must approve the use of cameras; please call 202–452–2955 for further information. If you need an accommodation for a disability, please contact Penelope Beattie on 202–452–3982. For the hearing impaired only, please use the Telecommunication Device for the Deaf (TDD) on 202–263–4869. Privacy Act Notice: The information you provide will be used to assist us in prescreening you to ensure the security of the Board’s premises and personnel. In order to do this, we may disclose your information consistent with the routine uses listed in the Privacy Act Notice for BGFRS–32, including to appropriate federal, state, local, or foreign agencies where disclosure is reasonably necessary to determine whether you pose a security risk or where the security or confidentiality of your information has been jbell on DSK30RV082PROD with NOTICES PLACE: VerDate Sep<11>2014 17:25 Apr 03, 2019 Jkt 247001 compromised. We are authorized to collect your information by 12 U.S.C. 243 and 248, and Executive Order 9397. In accordance with Executive Order 9397, we collect your SSN so that we can keep accurate records, because other people may have the same name and birth date. In addition, we use your SSN when we make requests for information about you from law enforcement and other regulatory agency databases. Furnishing the information requested is voluntary; however, your failure to provide any of the information requested may result in disapproval of your request for access to the Board’s premises. You may be subject to a fine or imprisonment under 18 U.S.C. 1001 for any false statements you make in your request to enter the Board’s premises. Dated: April 1, 2019. Ann Misback, Secretary of the Board. MATTERS TO BE CONSIDERED: In accordance with the Federal Advisory Committee Act, the CDC and the Health Resources and Services Administration (HRSA), announce the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is open to the public, limited only by 90 seats and 70 ports for audio phone lines. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipts is Monday, May 13, 2019. Persons who desire to make an oral statement, may request it at the time of the public comments period on May 14, 2019 at 4:30 p.m., EDT. DATES: The meeting will be held on May 14, 2019, 8:30 a.m. to 5:30 p.m., EDT and May 15, 2019, 8:30 a.m. to 12:30 p.m., EDT. ADDRESSES: CDC Corporate Square, Building 8, Conference Room 1–ABC, 8 Corporate Boulevard, Atlanta, Georgia 30329 and Web conference: 1–877–603– 4228, Participant code: 42598858 and https://adobeconnect.cdc.gov/chac/. FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E–07, Atlanta, Georgia 30329–4027, telephone (404) 639–8317; zkr7@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health 1. Proposed Rules on Prudential Standards for Foreign Banking Organizations and Resolution Plan Requirements for Foreign and Domestic Banking Organizations Notes: 1. The staff memos to the Board will be made available to attendees on the day of the meeting in paper and the background material will be made available on a compact disc (CD). If you require a paper copy of the entire document, please call Penelope Beattie on 202–452–3982. The documentation will not be available to the public until about 20 minutes before the start of the meeting. 2. This meeting will be recorded for the benefit of those unable to attend. The webcast recording and a transcript of the meeting will be available after the meeting on the Board’s public website https://www.federalreserve.gov/about thefed/boardmeetings/ or if you prefer, a CD recording of the meeting will be available for listening in the Board’s Freedom of Information Office, and copies can be ordered for $4 per disc by calling 202–452–3684 or by writing to: Freedom of Information Office, Board of Governors of the Federal Reserve System, Washington, DC 20551. FOR MORE INFORMATION PLEASE CONTACT: Michelle Smith, Director, or Dave Skidmore, Assistant to the Board, Office of Board Members at 202–452–2955. You may access the Board’s public website at www.federalreserve.gov for an electronic announcement. (The website also includes procedural and other information about the open meeting.) PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: SUMMARY: Discussion Agenda SUPPLEMENTARY INFORMATION: [FR Doc. 2019–06645 Filed 4–2–19; 11:15 am] E:\FR\FM\04APN1.SGM 04APN1 Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices professionals and the public about HIV/ AIDS, Viral Hepatitis and other STDs. Matters To Be Considered: The agenda will include discussions on (1) Prevention of Perinatal HIV, Viral Hepatitis, and Congenital Syphilis: Examples from the Field; (2) Ending the HIV Epidemic—Collaborating Across Geographic Boundaries and Responsibilities; (3) Hepatitis C Virus (HCV) Elimination: Institutional Models; (4) Dating Apps and STD/HIV Risk: Opportunities for Promotion, Prevention, Monitoring and Evaluation; and (5) Updates from Workgroups. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06607 Filed 4–3–19; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Mine Safety and Health Research Advisory Committee (MSHRAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Mine Safety and Health Research Advisory Committee (MSHRAC). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. If you wish to attend in person or by phone, please contact Marie Chovanec by email at MChovanec@ cdc.gov or by phone at 412–386–5302 at least 5 business days in advance of the meeting. DATES: The meeting will be held on May 6, 2019, 8:30 a.m.–4:30 p.m., EDT and on May 7, 2019, 8 a.m.–120 p.m. EDT. ADDRESSES: NIOSH Pittsburgh Campus, Building 140, Room 140MP, 626 Cochrans Mill Road, Pittsburgh, PA 15236, United States. jbell on DSK30RV082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:25 Apr 03, 2019 Jkt 247001 FOR FURTHER INFORMATION CONTACT: Jeffrey H. Welsh, Designated Federal Officer, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 15236, telephone 412–386–4040; email juw5@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This committee is charged with providing advice to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NIOSH, on priorities in mine safety and health research, including grants and contracts for such research, 30 U.S.C. 812(b)(2), Section 102(b)(2). Matters To Be Considered: The agenda will include discussions on mining safety and health research projects and outcomes, including updates from two MSHRAC Workgroups, the Health Advisory in the Mining Program Workgroup and the Metal Mining Automation and Advanced Technologies Workgroup; industrial minerals sector research priorities; translation of hand-arm vibration to the hearing canal; ground control challenges in Nevada weak rock; respirable dust control technology; EXAMiner hazard recognition training; slips, trips and falls research; health and safety management systems through safety climate; and lithium ion battery research. The meeting will also include updates from the NIOSH Associate Director for Mining, the Spokane Mining Research Division, the Pittsburgh Mining Research Division, the National Personal Protective Technology Laboratory and the Respiratory Health Division. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06604 Filed 4–3–19; 8:45 am] BILLING CODE 4163–19–P PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 13295 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, limited only by the space available. The meeting space accommodates approximately 150 people and the audio conference line has 150 ports for callers. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference (information below). DATES: The meeting will be held on April 17, 2019 from 8:30 a.m. to 6 p.m., EDT. A public comment session will be held on April 17, 2019 at 6 p.m. and conclude at 7 p.m. or following the final call for public comment, whichever comes first. ADDRESSES: Pittsburgh Marriott City Center, 112 Washington Place, Pittsburg, PA 15219; Phone: (412) 471–4000, Fax: (412) 394–1017 and audio conference call via FTS Conferencing. The USA toll-free dial-in number is 1 (866) 659– 0537; the pass code is 9933701. Web conference by Skype: Meeting CONNECTION: https:// webconf.cdc.gov/zab6/yzdq02pl?sl=1. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E–20, Atlanta, Georgia 30329, Telephone (513) 533–6800, Toll Free 1(800) CDC–INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include SUMMARY: E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 84, Number 65 (Thursday, April 4, 2019)]
[Notices]
[Pages 13294-13295]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06607]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHACHSPT)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
and the Health Resources and Services Administration (HRSA), announce 
the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is 
open to the public, limited only by 90 seats and 70 ports for audio 
phone lines. Time will be available for public comment. The public is 
welcome to submit written comments in advance of the meeting. Comments 
should be submitted in writing by email to the contact person listed 
below. The deadline for receipts is Monday, May 13, 2019. Persons who 
desire to make an oral statement, may request it at the time of the 
public comments period on May 14, 2019 at 4:30 p.m., EDT.

DATES: The meeting will be held on May 14, 2019, 8:30 a.m. to 5:30 
p.m., EDT and May 15, 2019, 8:30 a.m. to 12:30 p.m., EDT.

ADDRESSES: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8 
Corporate Boulevard, Atlanta, Georgia 30329 and Web conference: 1-877-
603-4228, Participant code: 42598858 and https://adobeconnect.cdc.gov/chac/.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07, 
Atlanta, Georgia 30329-4027, telephone (404) 639-8317; [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: This committee is charged with advising the Director, CDC 
and the Administrator, HRSA, regarding activities related to prevention 
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education of 
health

[[Page 13295]]

professionals and the public about HIV/AIDS, Viral Hepatitis and other 
STDs.
    Matters To Be Considered: The agenda will include discussions on 
(1) Prevention of Perinatal HIV, Viral Hepatitis, and Congenital 
Syphilis: Examples from the Field; (2) Ending the HIV Epidemic--
Collaborating Across Geographic Boundaries and Responsibilities; (3) 
Hepatitis C Virus (HCV) Elimination: Institutional Models; (4) Dating 
Apps and STD/HIV Risk: Opportunities for Promotion, Prevention, 
Monitoring and Evaluation; and (5) Updates from Workgroups. Agenda 
items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06607 Filed 4-3-19; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.